CAD & ACS & CHF Flashcards

(36 cards)

1
Q

Risk Factors of CAD

A

NM: age, gender, ethnicity, family HX, genetic
M: hyperlipidemia, HTN, Tobacco use, physical inactivity, obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CAD: contributing factors

A

Elevated homocysteine levels
- Breakdown of AA
DM
Metabolic syndrome
- Increased waist circ
- HTN
- abnormal serum lipids
- elevated fasting glucose
Stress
Substance abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Angina

A

Clinical manifestation of REVERSIBLE myocardial ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MI (Myocardial infarction)

A

IRREVERSIBLE necrosis caused by abrupt decrease or cessation of coronary blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Assessment of chest pain

A

location
duration
quality
radiation
precipating factor
medication relief
EKG changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gender differences in cardiac disorders

A

Prodromal symtoms
women:
-fatigue, SOB, indigestion, anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Core measures: ACS

A

ST elevation or new BBB
- thrombolytic ( clot busting drugs) within 30 mins of hospital arrival
- PCI within 45-90 mins of hospital arrival
ASA within 24-hours of hospital arrival
Admission to CCU within 30 mins after initial EKG (STEMI)
smoking cessation education
Discharge RX
- B-Blockers
- ACE1/ARB for EF less than 40%
- ASA
Cardiac Phase I activity standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Medical management of UA or NSTEMI w/ negative markers & on-going angina

A

-ASA
-heparin (IV or LMWH)
- glycoprotein inhibitor (Integrillin)
- Angio w/ PCI when stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Medical management of STEMI or NSTEMI w/ positive markers

A

reperfusion therapy
- emergent PCI
- Fibrinolytic therapy
- Surgical revascularization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Creatine Kinase (total CK)

A

used to support Dx of myocardial injury, neurologic or skeletal muscle disease
levels rise 6-hours after injury, peak 18-hours, normalize in 2-3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Isoenzymes

A

CK-MM 100% (all circulating CK, muscle injury)
CK-MB 0% (specific for cardiac cells)
- usually do NOT rise with angina, PE, CHF
- Rise 3-6 hours, peak 12- 24 hours, normalize 12- 48 hours
- quantify degree of MI & timing of onset
Shock, malignant hyperthermia, myopathy, myocarditis
- rise in unstable angina signifies increased risk of MI
Determine appropriateness of thrombylotic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Troponins

A

Specific indicator of cardiac injury
determines if chest pain is caused by cardiac ischemia
helps predict risk of future events
- elevate sooner & remain elevated longer ( 7-14 days)
Diagnosis MI

Troponin T: less than .2 ng/ml
Troponin I: less than .3 ng/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Medical management of CAD/Angina

A

Restoration of blood supply
Precutaneous coronary intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nursing management of CAD

A

modifiable risk factor reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sex activity CAD

A

7-10 days without complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications of AMI/ACS

A

Dysrhythmias
cariogenic shock
papillary muscle dysfunction or rupture
pericarditis (pericardial friction rub)
- Dressler syndrome= pericarditis + effusion + fever
Venticular aneurysm
- thrombi= lead to stroke
Ventricular rupture

17
Q

Pathophysiology of HF

A

Ventricular dilation
Increased SNS stimulation
Stimulation RAAS
De-compensated HF
- Pulmonary edema

18
Q

Left-ventricular Failure

A

Back-up to LA into pulmonary veins leads to increased pulmonary pressure leads to pulmonary congestion, pulmonary edema

19
Q

Right-ventricular failure

A

back up to RA & venous circulation leads to systemic congestion leads to Jugular vein distention, hepatomegaly, splenomegaly, GI vascular congestion, Peripheral edema

20
Q

Complication of HF

A

Pleural effusion
Dysrhythmias
LV thrombus
Hepatomegaly
Renal failure

21
Q

Diagnostics of HF

A

ANP/BNP
Echocardigram
Doppler flow
Chest X-Ray
EKG
ABG analysis
Liver enzymes
BUN/Cr

22
Q

Atrial natriuretic peptide (ANP)

A

22-77pg/ml
Synthesized in cardiac muscle

23
Q

Brain natriuretic peptide (BNP)

A

100 less pg/mL
main source cardiac ventricle
d/t atrial / ventricular stretch causing
- vaso-relaxation
- inhibition of adrenal aldosterone secretion
- inhibition of RAAS
Implications of HTN, CHF, Atherosclerosis

Ventricular peptide

24
Q

Management of HF

A

Improve ventricular (pump) performance
Reduce workload
Reduce fluid retention
Reduce stress & risk of injury

Medications
- diuretics
- vasodilators
- Morphine
- Positive Inotropes
- digoxin (LV function)
- loading dose; not for initial treatment
Surgical:
- transplantation

25
Nursing management of HF
Interventions to address: - Activity intolerance - Decreased CO - Excess fluid volume (fluid restriction) - Fatigue - Impaired gas ex - Ineffective health maintenence - Fear
26
Functional Classification of Heart Disease
Class I - no limit of physical act Class II - Slight limitation of physical activity, no symptoms at rest, ordinary physical activity results in fatigue, dyspnea, palpations, or angina Class III - Limits of physical act, comfortable at rest. Ordinary physical activity causes fatigue, dyspnea, palpations, or angina Class IIII - Inability to carry on any physical activity w/o discomfort. symptoms of cardiac insufficiency or of angina may be present even at rest. If any physical activity is undertaken, discomfort is increased
27
Mitral valve prolapse
Physio - Valve leaflet prolapse or "buckle" back into LA during systole - Usually benign Manifestation -Palpitations d/t dysrhythmias - PVCs, PSVT, VT - +/- chest pain - Prophylactic antibiotics
28
Mitral stenosis
adult causes from rheumatic heart disease obstruction increase left atrial pressure and volume hypertrophy of pulmonary vessels chronic LA pressure elevation Physio Increase in LA pressure/volume Increased pulmonary pressure Hypertrophy of pulmonary vessels Manifest Exceptional dyspnea Fatigue Palpitations (AFib) Hoarseness - LA pressing on laryngeal nerve Chest pain Seizure/stroke
29
Mitral regurgitation
Causes MI Chronic rheumatic heart disease Mitral valve prolapse Ischemic papillary muscle dysfunction Infective endocarditis Physiology Incomplete valve closure during systole Blood flows backward from LV to LA LV & LA work harder to maintain C.O. (Chronic) LA enlargement LV hypertrophy Decrease in C.O. Symptoms Weakness Fatigue Palpitations Dyspnea gradually progresses to Orthopnea Paroxysmal nocturnal dyspnea Peripheral edema ACUTE manifestations Thready pulses Cool, clammy extremities Low C.O. may mask murmu Sudden – Pulmonary edema & cardiogenic shock CHRONIC manifestations May be asymptomatic for years until development of some degree of LV failure Weakness / fatigue Palpitations Progressive dyspnea
30
Aortic stenosis
Congenital: Usually childhood, adolescence, or young adulthood Later in life usually Rheumatic fever Fusion of commissures Calcification of leaflets (Stiffness, retraction) Accompanied by MV disease Senile fibrocalcific degeneration of normal valve Isolated AS almost always non-rheumatic Obstruction of flow from LV to aorta during systole Reduced C.O. – decreased tissue perfusion Pulmonary HTN – Heart failure Effect LV hypertrophy ↑ myocardial oxygen consumption d/t ↑ mass ↓ CO & pulmonary HTN Clinical manifestations Angina Syncope Exertional dyspnea Triad = LV failure Poor prognosis Symptoms Obstruction not relieved Nitroglycerin contraindicated** Reduces preload
31
Aortic stenosis
Congenital: Usually childhood, adolescence, or young adulthood Later in life usually Rheumatic fever Fusion of commissures Calcification of leaflets (Stiffness, retraction) Accompanied by MV disease Senile fibrocalcific degeneration of normal valve Isolated AS almost always non-rheumatic Obstruction of flow from LV to aorta during systole Reduced C.O. – decreased tissue perfusion Pulmonary HTN – Heart failure Effect LV hypertrophy ↑ myocardial oxygen consumption d/t ↑ mass ↓ CO & pulmonary HTN Clinical manifestations Angina Syncope Exertional dyspnea Triad = LV failure Poor prognosis Symptoms Obstruction not relieved Nitroglycerin contraindicated** Reduces preload
32
Aortic regurgitation
May result from disease of aortic valve leaflets, aortic root, or both Caused by Infective endocarditis Trauma Aortic dissection Chronic AR results from Rheumatic heart disease Congenital bicuspid aortic valve Syphilis Chronic rheumatic heart conditions Acute manifestations Sudden manifestations of CV collapse Severe dyspnea & chest pain Hypotension LV failure Cardiogenic shock Chronic manifestations May be asymptomatic for years Progressive exertional dyspnea “Water-hammer” pulse A strong quick beat that collapses immediately Physiology Retrograde blood flow from ascending aorta to left ventricle Results in volume overload Left ventricle compensates by dilation & hypertrophy Myocardial contractility eventually declines Pulmonary hypertension & right ventricular failure develop Clinical manifestations of sudden cardiovascular collapse Left ventricle exposed to aortic pressure during diastole Sudden weakness Severe dyspnea Chest pain Hypotension Constitutes a medical emergency
33
Classification of Murmurs
Timing Shape Location Radiation Intensity Pitch Quality Grade 1 – Very faint Grade 2 – Soft Grade 3 – Heard all over the precordium Grade 4 – Loud, with palpable “thrill” Grade 5 – Very loud, with palpable “thrill” May be heard with stethoscope partially off chest Grade 6 – Very loud, with thrill May be heard with stethoscope entirely off chest
34
Diagnostic studies
History & physical exam Chest x-ray ECG Cardiac catheterization Echocardiogram & Doppler flow studies Evaluation of cardiac wall motion (function) Detect valvular heart disease Stress testing Identify / quantify pericardial fluid Color doppler imaging demonstates direction & velocity of blood flow TEE: Trans-esophageal echocardiography Patent ductus arteriosus (PDA)
35
Drug therapy
Digoxin (positive inotrope) Vasodilators Diuretics -Blockers Other drug therapies Anti-coagulants Anti-arrythmics Low-sodium diet
36
Nursing Assessment
Objective data Abnormal heart sounds Tachycardia Dysrhythmias Hypotension Hepatomegaly Diaphoresis Peripheral edema Ascites Crackles, wheezes, hoarseness